ROSENDALE MARTIN P 4
4 · CYTOMEDIX INC · Filed Feb 10, 2012
Insider Transaction Report
Form 4
CYTOMEDIX INCCMXI
ROSENDALE MARTIN P
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Conversion
Common Stock
2012-02-08+35,843→ 130,329 total - Other
Common Stock
2012-02-08+2,000→ 132,329 total
Footnotes (2)
- [F1]The reporting person converted his shares of the Series D Convertible Preferred Stock at a conversion price of $0.558 per share.
- [F2]Represents shares of stock dividend on the Series D Convertible Preferred Stock.